• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Disruptive technology: Advanced computing comes to health care

Disruptive technology: Advanced computing comes to health care

April 30, 2011 By MassDevice Contributors Network

By Keeley Wray

The recent Bio-IT World meeting featured some exciting forecasts about disruptive healthcare advances from advanced computing technology.

We’re closer than ever to process streamlining, artificial intelligence and combining the best ideas from other industries.

Many themes I like to blog about — clinical decision support, data visualization, patient-entered health data — were addressed provocatively in the talks. Here are some trends I’m watching.

Vector logo

• New data visualization systems will increase scientific productivity. Keynote speaker Bryn Roberts of Hoffmann-La Roche demoed a futuristic, multi-touch tool for reviewing and designing compound molecules, built with the help of Accelrys. The working surface is at least ten times the size of a computer screen. It allows chemists to visualize molecules by rotating them and zooming in, add notes or different chemistry groups sift through different sets of molecules and organize them in clusters, and email pieces of information to team members for review. Watching the video, I could see that this system beckoned a new type of human interface interaction. The tool reminded me of the virtual imaging technology used in Star Wars to depict the Death Star and other three dimensional objects. The large screen draws the eye to structurally important features of the molecules, and images can be explored using one’s hands. The information is easier to organize. Playing with the demo at the Accelerys booth, I wished they’d design an interface to manage my social networks. I could add notes, see global trends and establish relationships between objects much more easily than I do now. Maybe in Facebook 2.0.?

• Patients become empowered by sharing their own data. Speaking of social networks, I was excited to learn more about PatientsLikeMe from founder Ben Heywood. PatientsLikeMe is a website that allows patients with similar diagnoses to connect and share experiences and ideas, helping them achieve the best possible outcomes and quality of life. The information offered by the site goes far beyond what two users can share in a web conversation. Beautiful, brightly colored graphical tools allow patients to visualize trends in the data – their own and that of others with similar diagnoses — potentially providing additional wisdom not currently offered by conventional medicine. One interesting screen shot compared the frequency of side effects reported during the clinical trial for a particular medication with the significantly higher frequency reported by users of PatientsLikeMe. It will be interesting to follow this platform’s progress and see how it and other health social networks begin to integrate, providing a more centralized means of obtaining health advice.

• Knowledge engines will inform about disease, using crowd-sourced health data. Stephen Wolfram, creator of Mathematica, believes we’ll soon have the tools to use health data to model a patient’s disease, anticipate adverse events or suggest personalized treatment options. His new knowledge engine,Wolfram|Alpha, could be loaded with high volumes of data, much of it coming from patients themselves. Individual users could query the system, drawing upon the models it generates, and receive support for healthcare-related decisions. As users begin to load data directly from wearable, automated sensors, rather than entering it manually, the messiness typically associated with crowd-sourced data will begin to dissolve. Also, because patients will be voluntarily entering information, their data would not be subject to the privacy rules governing data collected by a health institution.

Compared with the banking and consumer product industries, healthcare has been a dinosaur when it comes to using advanced computational approaches. But I think in the near future we will see measurable change. I hope the healthcare and pharma industries will be dramatically different by the time I reach my old age – if so, we’ll have these three leaders and others I met at the conference to thank.

Top image: “Wooden Wheels” by Bill Swingle acquired on Flickr.

Filed Under: News Well, Software / IT Tagged With: Boston Children's Hospital, Vector Blog

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy